A Florence woman told us how a modern COPD treatment at Christ Hospital helped her to be able to do things she couldn't do ...
Discover how cell-based therapy is emerging as a promising treatment option for COPD patients. Learn about its benefits, ...
BAGUIO CITY (PIA) — The Baguio General Hospital and Medical Center (BGHMC) is encouraging individuals with persistent respiratory symptoms to go for early checkup to detect and prevent Chronic ...
Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced the completion of its Phase IIa clinical study for 9MW1911, a self-developed ...
The procedure is called bronchoscopic lung volume reduction. It involves inserting small valves into the air tubes of the ...
Unlike the West, where smoking remains the dominant driver, India’s COPD burden is shaped by pollution, says Dr Anurag ...
The 2026 version of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy report has been published. Key ...
The new framework, which classifies the severity of exacerbations of COPD based on three key factors was developed by the ...
Glenmark Pharmaceuticals has launched a groundbreaking nebulised triple therapy for COPD. This single, easy-to-use treatment ...
She told us her life changed when she sought treatment at Christ Hospital and met Dr. Duane Allen, a pulmonary and critical ...
The global monoclonal antibody for asthma and COPD market size was valued at USD 34.02 billion in 2025 and is predicted to ...
Clinical Trials Arena on MSN
Mabwell’s mAb leads to 40% reduction in severe COPD exacerbations
A Chinese Phase IIb trial of the mAb has already started, with Mabwell also hoping to initiate a Phase IIa trial in the US.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈